Telix Pharma
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine 2023-02-15 04:51
Telix Reports Fourth Quarter 2022 Financial Results 2023-01-18 08:50
Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update 2023-01-09 06:37
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances 2022-12-22 06:04
Telix Announces Executive Leadership Appointments 2022-12-05 06:39
Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand 2022-11-22 20:00
First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy 2022-11-22 04:59
Telix Acquires Optimal Tracers 2022-11-14 06:36
Telix to Present at Jefferies London Healthcare Conference 2022 2022-11-11 20:00
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study 2022-11-07 06:48
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022 2022-10-27 10:23
Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide 2022-10-27 06:44
Telix Reports Third Quarter 2022 Financial Results 2022-10-20 06:09
TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM 2022-10-18 06:43
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market 2022-10-17 13:00
Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging 2022-10-17 07:25
Health Canada Approves Illuccix® for Prostate Cancer Imaging 2022-10-14 08:21
First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent 2022-09-30 02:30
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate 2022-09-28 06:50
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent 2022-09-28 05:00
1 3 4 5 6 7